CEO Chaplin explains how Kardium packed the power of the globe into its PFA cardiac ablation device

DeviceTalks Podcast Network

Jun 21 2024 | 00:48:11

00:00 / 00:48:11

Episode • June 21, 2024 • 00:48:11

Hosted By

Show Notes

In this episode of the DeviceTalks Weekly podcast, Kevin Chaplin, CEO of Kardium, a Vancouver-based electrophysiology device company, shares details of the company’s Globe® Pulsed Field Mapping and Ablation System. With $100 million in new capital, the company is poised to open a new front in the pulsed-field ablation battle. Thank you to Freudenberg Medical for sponsoring this episode. Go to Freudenbergmedical.com for more information. Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe now to the DeviceTalks Podcast Network so you don’t miss a future episode.

The Complete History of the Sapien TAVR – from PVT’s Emerging Idea to Edwards Lifesciences' Success

Edward Lifesciences’ acquisition of Percutaneous Valve Technologies helped mark the birth of one of medtech’s great game-changers – the development of the transcatheter aortic...

Play

01:28:03

Cerenovus’ Mark Dickinson on building a neurovascular portfolio; early peek at DT Boston

In this episode, Tom Salemi interviews Mark Dickinson, worldwide president at Cerenovus, the neurovascular business at Johnson & Johnson Medtech. Mark Dickinson shares his...

Play

01:04:40

Building the Cologuard and the fight against colorectal cancer with Exact Sciences Graham Lidgard

Colon cancer is one of the most preventable cancers, yet it is also one of the deadliest forms of the disease. In this episode,...

Play

00:36:48

Show Notes

Other Episodes

The Complete History of the Sapien TAVR – from PVT’s Emerging Idea to Edwards Lifesciences' Success

Cerenovus’ Mark Dickinson on building a neurovascular portfolio; early peek at DT Boston

Building the Cologuard and the fight against colorectal cancer with Exact Sciences Graham Lidgard